Position in MRK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,855,000
+$366,590 QoQ
Shares Held
30,000
+3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,167
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PKO Investment Management Joint-Stock Co holds $45,805,043 across 9 Drug Manufacturers - General names. MRK ranks #7 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,750 | $10,495,013 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,500 | $7,390,890 | |
| 3 | JNJ |
Johnson & Johnson
|
28,200 | $7,161,954 | |
| 4 | AMGN |
Amgen Inc
|
16,400 | $5,938,768 | |
| 5 | ABBV |
AbbVie Inc.
|
21,200 | $5,334,768 | |
| 6 | PFE |
Pfizer Inc
|
166,450 | $4,008,116 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
30,000 | $3,855,000 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
21,000 | $1,210,020 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,855,000 | 30,000 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,488,410 | 29,000 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,473,580 | 33,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $6,032,468 | 71,875 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $6,125,005 | 77,375 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $4,747,585 | 52,892 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $4,245,408 | 42,676 | Shares | Sole | 2025-03-13 | |
| 2024-09-30 | $3,937,806 | 34,676 | Shares | Sole | 2025-03-13 | |
| 2024-06-30 | $3,550,088 | 28,676 | Shares | Sole | 2025-03-13 | |
| 2024-03-31 | $3,783,798 | 28,676 | Shares | Sole | 2025-03-13 | |
| 2023-12-31 | $3,562,337 | 32,676 | Shares | Sole | 2025-03-13 | |
| 2023-09-30 | $3,127,209 | 30,376 | Shares | Sole | 2025-03-13 | |
| 2023-06-30 | $4,947,461 | 42,876 | Shares | Sole | 2025-03-13 | |
| 2023-03-31 | $4,189,212 | 39,376 | Shares | Sole | 2025-03-13 | |
| 2022-12-31 | $4,146,867 | 37,376 | Shares | Sole | 2025-03-13 | |
| 2022-09-30 | $3,735,541 | 43,376 | Shares | Sole | 2025-03-13 | |
| 2022-06-30 | $4,298,756 | 47,151 | Shares | Sole | 2025-03-13 | |
| 2022-03-31 | $4,607,189 | 56,151 | Shares | Sole | 2025-03-13 | |
| 2021-12-31 | $7,877,825 | 102,790 | Shares | Sole | 2025-03-13 | |
| 2021-09-30 | $5,338,368 | 71,074 | Shares | Sole | 2025-03-13 | |
| 2021-06-30 | $3,762,668 | 48,382 | Shares | Sole | 2025-03-13 | |
| 2021-03-31 | $1,762,509 | 22,863 | Shares | Sole | 2025-03-13 | |
| 2020-12-31 | $1,870,192 | 22,863 | Shares | Sole | 2025-03-13 | |
| 2020-09-30 | $1,896,486 | 22,863 | Shares | Sole | 2025-03-13 | |
| 2020-06-30 | $1,767,996 | 22,863 | Shares | Sole | 2025-03-13 | |
| 2020-03-31 | $1,759,078 | 22,863 | Shares | Sole | 2025-03-13 | |
| No filing history on record for this holder in this stock. | ||||||